Mapping Psychosocial Screening to Services for Children With Cancer

Sponsor
The Hospital for Sick Children (Other)
Overall Status
Completed
CT.gov ID
NCT04132856
Collaborator
Centre for Addiction and Mental Health (Other)
38
1
2
29.1
1.3

Study Details

Study Description

Brief Summary

Children with cancer are vulnerable to symptoms of anxiety and depression. Although screening for psychosocial distress is a standard of care for children with cancer, there is a limited knowledge

Condition or Disease Intervention/Treatment Phase
  • Other: Psychosocial Navigator
  • Other: Communication of Summary Profile
N/A

Detailed Description

Background: Approximately 3 000 children and adolescents are diagnosed with cancer in Canada each year [Canadian Cancer Society]. Children with cancer experience higher rates of anxiety and depression symptoms relative to healthy controls [Pinquart & Shen, 2011], and a subgroup are vulnerable to marked levels of psychological distress [Kurtz & Abrams, 2011]. One standard for psychosocial care in pediatric cancer that is starting to be implemented across the United Stated and Canada is the systematic screening for psychosocial distress, using the Psychosocial Assessment Tool (PAT) [Kazak, Schneider, Didonato, Pai, 2015; Pai et al., 2008; Barrera et al., 2014; McCarthy et al., 2009; Sint Nicolaas et al., 2016]. However, a dearth of literature exists on how to bridge screening for psychosocial distress and the delivery of appropriate evidence-based mental health resources. The current study is a randomized controlled pilot intervention project which aims to test the feasibility and effects of introducing a psychosocial navigator who will coordinate the delivery of psychosocial resources to children with cancer and their families based on early screening and follow-up for psychosocial distress. Specific Objectives: 1) To determine the feasibility and utility of conducting psychosocial screening and providing an Enhanced Psychosocial Intervention (EPSI). 2) To examine the effects of EPSI, as compared to treatment as usual (TAU+), on the mental health, quality of life, coping, and social relationships of children with cancer. Methods: A randomized controlled feasibility intervention trial, with a TAU+ control group, will be conducted with newly diagnosed children with any type of cancer. Participants will be 10-18 years of age, medically suitable for participation, in active treatment, and the primary caregiver. Forty-eight child-caregiver dyads (24 in the intervention and 24 in the control group) will be enrolled. The EPSI will have two components: 1) Information about the psychosocial risk of the family and mental health of the child (e.g., depression) and 2) the Psychosocial Navigator (PSN) as resource for tailoring psychosocial resources to child-family distress, linking with the treating team. Measures of feasibility (recruitment, acceptability) will be documented throughout; initial screening using the PAT will be conducted 2-4 weeks post diagnosis (baseline); and using the distress thermometer, follow-up will be done at specific periods depending on the disease (leukemia/lymphoma, solid tumors, brain tumors). The primary psychosocial outcome (depression), and secondary outcomes (post-traumatic stress, pain, fatigue, coping, sleep quality, time and financial cost, social support and quality of life) will be completed at baseline and 12 months later. Descriptive statistics (frequency and percentage rates) will be provided for feasibility measures and PAT psychosocial risk categories. Means, standard deviations, and ranges will be provided for the primary and secondary outcomes. Preliminary analyses of group comparisons will also be performed via independent t tests and chi square tests. Further, analyses of covariance (ANCOVAs) will be conducted on the primary and secondary outcomes to test group differences at post-test while controlling for pretest scores.

Significance: The proposed intervention project will assess and address the psychosocial needs of newly diagnosed pediatric cancer patients and families. This intervention aims to improve the triaging of resources and enhance the effectiveness of psychosocial intervention for children with cancer. The enhanced intervention is expected to improve children's and adolescents' coping with disease-related stressors such as pain and uncertainty, improve their mood, and enhance social engagement with peers.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Screening
Official Title:
Mapping Psychosocial Screening to Services for Children With Cancer: Feasibility and Pilot Study
Actual Study Start Date :
Nov 27, 2017
Actual Primary Completion Date :
Apr 30, 2020
Actual Study Completion Date :
Apr 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

The Intervention group will receive the services of the Psychosocial Navigator (PSN) monthly for the full 12 months of the study. At baseline, the PSN will provide the health care providers (HCPs) and family with recommendations for mapping and triaging of resources to levels of psychosocial risk (PAT: Universal, Targeted, Clinical) and level of depression and anxiety (mild, moderate, and high mental health problems; as determined by the standardized norms for the measures). This information will be summarized in the Communication Summary Profile and shared with the treating team (oncologist, nurse, and Social Worker, core psychosocial staff involved in the child's care) and family within 48 hours of completion. The PSN will conduct follow-up psychosocial screenings on a monthly basis, using the Distress Thermometer for children and caregivers. Results of the monthly assessments and recommended resources will also be communicated to the caregiver/parent and treating team of the youth.

Other: Psychosocial Navigator
Services of psychosocial navigator

Other: Communication of Summary Profile
Both patient/caregiver dyad and HCPs will receive a summary of the PAT results and levels of depression and anxiety.

No Intervention: Treatment as Usual Group

Current psychosocial care services will be accessible to Treatment as Usual Group (e.g., social work, child life, psychology, art and music therapy, and psychiatry).

Outcome Measures

Primary Outcome Measures

  1. Feasibility pertaining to recruitment [12 months]

    Rate of recruitment as measured by percentage of participants who consent to participation as compared to those who are eligible and do not consent

  2. Feasibility pertaining to retention [12 months]

    Rates of completed questionnaires at all time points

  3. Satisfaction with Enhanced Intervention as assessed by questionnaire at completion of study [12 months]

    5 - point likert scale satisfaction questionnaire with 6 questions pertaining to usefulness and overall satisfaction with the enhanced intervention. The minimum score is 6 (low satisfaction) and the maximum score is 30 (high satisfaction).

  4. Satisfaction with Enhanced Intervention as assessed by semi-structured interview at completion of study [12 months]

    Semi-structured interview with 6 questions including "What were your expectations about being in this study?"; "Were your expectations of the study met?"; "Do you have any additional comments/suggestions for the study?"

Secondary Outcome Measures

  1. Distress [Change from baseline to 12 months]

    Pediatric and Adult Distress Thermometer (self-report) measures participant distress on a visual analog scale of 1 to 10, with a score of 10 indicating high distress

  2. Patient generic quality of life based on self report [Change from baseline to 12 months]

    Pediatric Quality of Life - generic. (Child/teen self-report). Measures perceived quality of life of child with cancer based on self perception - on everyday items (for children who do not have cancer). Miinimum score is 0. Maximum score is 100. Higher score indicates better perceived quality of life.

  3. Patient generic quality of life based on caregiver report [Change from baseline to 12 months]

    Pediatric Quality of Life - generic. (Caregiver-report). Measures perceived quality of life of child with cancer based on caregiver perception - on everyday items (for children who do not have cancer). Miinimum score is 0. Maximum score is 100. Higher score indicates better perceived quality of life.

  4. Patient quality of life as it relates to cancer, based on self-report [Change from baseline to 12 months]

    Pediatric Quality of Life-Cancer (Child/teen self-report). Measures perceived quality of life of child with cancer based on self-perception. Miinimum score is 0. Maximum score is 100. Higher score indicates better perceived quality of life.

  5. Patient quality of life as it relates to cancer, based on caregiver report [Change from baseline to 12 months]

    Pediatric Quality of Life-Cancer (Caregiver report). Measures perceived quality of life of child with cancer based on caregiver perception. Miinimum score is 0. Maximum score is 100. Higher score indicates better perceived quality of life.

  6. Patient anxiety and depression - child/teem self report [Change from baseline to 12 months]

    Pediatric Index of Emotional Distress. Minimum score is 0. Maximum score is 42. Lower score indicates lower levels of anxiety and depression.

  7. Patient anxiety (child/teen self-report) [Change from baseline to 12 months]

    Patient-reported Outcomes Measurement Information System (PROMIS) - pediatric anxiety questionnaire - short form (child/teen self-report). Minimum score is 8. Maximum score is 40. Lower score indicates lower level of anxiety.

  8. Patient depression (child/teen self-report) [Change from baseline to 12 months]

    Patient-reported Outcomes Measurement Information System (PROMIS) - pediatric depression questionnaire - short form (child/teen self-report). Minimum score is 8. Maximum score is 40. Lower score indicates lower level of depression.

  9. Caregiver post-traumatic stress related to child's cancer diagnosis [Change from baseline to 12 months]

    Impact of Events scale - Revised (IES-R) (caregiver self-report). Mimimum score is 0. Maximum score is 88. Lower scores indicate lower levels of post-traumatic stress.

  10. Patient post-traumatic stress related to own cancer diagnosis [Change from baseline to 12 months]

    Impact of Events scale - Revised (IES-R) (child/teen self-report). Mimimum score is 0. Maximum score is 88. Lower scores indicate lower levels of post-traumatic stress.

  11. Caregiver coping with stress of child's cancer diagnosis [Change from baseline to 12 months]

    Responses to Stress Questionnaire - Cancer Version (caregiver self-report). Minimum score is 0. Maximum score is 1. A higher score indicates more engagement with active coping strategies.

  12. Patient's own coping with stress of cancer diagnosis [Change from baseline to 12 months]

    Response to Stress Questionnaire - Cancer Version (patient self-report). Minimum score is 0. Maximum score is 1. A higher score indicates more engagement with active coping strategies.

  13. Psychosocial risk [Change from baseline to 12 months]

    Psychosocial Assessment Tool (PAT) (caregiver report). Minimum score is 0. Maximum score is 3. Lower score indicates lower level of psychosocial risk.

  14. Financial impact of pediatric cancer diagnosis and treatment on families. [Change from baseline to 12 months]

    Financial burden questionnaire (caregiver report). Minimum score is 22. Maximum score is 88. Higher score indicates lower level of financial impact on families.

  15. Caregiver depression [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Questionnaire (caregiver self-report). Minimum score is 6. Maximum score is 30. Lower scores indicate lower levels of depression.

  16. Caregiver anxiety [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Questionnaire (caregiver self-report). Minimum score is 6. Maximum score is 30. Lower scores indicate lower levels of anxiety.

Other Outcome Measures

  1. Sleep duration and quality of sleep of patient and caregiver [Change from baseline to 12 months]

    Pittsburgh Sleep Quality Index. (Caregiver and patient self-report). Minimum value is 0. Maximum value is 21. Lower scores indicate better sleep quality.

  2. Caregiver emotional support [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support Questionnaire (caregiver self-report). Minimum score is 6. Maximum score is 30. Higher scores indicate higher levels of emotional support.

  3. Caregiver Fatigue [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Questionnaire (caregiver self-report). Minimum score is 6. Maximum score is 30. Lower scores indicate lower levels of fatigue

  4. Patient Peer Relationships [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Perceived Quality of Peer Relationships (child/teen self-report). Minimum score is 8. Maximum score is 40. Higher scores indicate higher levels of perceived peer relationship quality.

  5. Patient Fatigue [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Questionnaire (child/teen self-report). Minimum score is 10. Maximum score is 50. Lower scores indicate lower levels of fatigue.

  6. Patient emotional support [Change from baseline to 12 months]

    Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support Questionnaire (child/teen self-report). Minimum score is 7. Maximum score is 35. Higher scores indicate higher levels of emotional support.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Between 10 and 18 years of age

  • Clinical diagnosis of cancer

  • Less than 4 weeks since diagnosis disclosure

  • Primary caregiver must also consent to participation

Exclusion Criteria:
  • Cancer diagnosis disclosed more than 4 weeks ago.

  • Primary caregiver declines to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital for Sick Children Toronto Ontario Canada M4G 3R9

Sponsors and Collaborators

  • The Hospital for Sick Children
  • Centre for Addiction and Mental Health

Investigators

  • Principal Investigator: Maru Barrera, PhD, The Hospital for Sick Children

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Maru Barrera, Principal Investigator, The Hospital for Sick Children
ClinicalTrials.gov Identifier:
NCT04132856
Other Study ID Numbers:
  • 1000056445
First Posted:
Oct 21, 2019
Last Update Posted:
Oct 22, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Maru Barrera, Principal Investigator, The Hospital for Sick Children

Study Results

No Results Posted as of Oct 22, 2020